Clinical Trial Update: Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

The Phase 2 trial of proton chemoradiotherapy for high-risk soft tissue sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: University of Florida | Conditions: Soft Tissue Sarcomas | Phase 2 | Status: WITHDRAWN